Abstract | BACKGROUND: RESULTS: CONCLUSIONS: Gene-combined EPCs represent a potential new therapeutic agent for the treatment of neovascular eye diseases.
|
Authors | Jing Ai, Jian Ma, Zhi-Qing Chen, Jun-Hui Sun, Ke Yao |
Journal | BMC molecular and cell biology
(BMC Mol Cell Biol)
Vol. 21
Issue 1
Pg. 57
(Jul 29 2020)
ISSN: 2661-8850 [Electronic] England |
PMID | 32727534
(Publication Type: Journal Article)
|
Chemical References |
- Endostatins
- Platelet Endothelial Cell Adhesion Molecule-1
- RNA, Messenger
- Vascular Endothelial Growth Factors
- Oxygen
|
Topics |
- Animals
- Disease Models, Animal
- Endostatins
(genetics, therapeutic use)
- Endothelial Progenitor Cells
(metabolism)
- Fluorescein Angiography
- Fundus Oculi
- Genetic Therapy
- Lentivirus
(genetics)
- Oxygen
- Platelet Endothelial Cell Adhesion Molecule-1
(metabolism)
- RNA, Messenger
(genetics, metabolism)
- Rats, Sprague-Dawley
- Retinal Neovascularization
(therapy)
- Vascular Endothelial Growth Factors
(metabolism)
|